Veru Inc (($VERU)) has held its Q4 earnings call. Read on for the main highlights of the call. Veru Inc. Balances Clinical Breakthroughs With ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

Results matter. Reviewing some of the top quotes from Senior Housing News stories of 2025, this emerges as a key theme. Many ...

Epic plans to expand the role of artificial intelligence across its EHR platform in 2026, with a focus on embedding AI directly into ...

As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...

As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The adoption of the FAIR model was pivotal in transforming our cybersecurity strategy into a measurable, business-aligned framework.

Galapagos offers deep value with €3B cash, a focused M&A strategy, and new leadership. Click here to read an analysis of GLPG ...

Monitor your heart health with precision right at your wrist with the best smartwatch with ECG in India, from popular brands ...

Let's see why this biotech is getting attention on Monday. The post Telix shares storm higher on big US and China news appeared first on The Motley Fool Australia.

On December 2, 2025, Ventyx Biosciences, Inc. (NASDAQ:VTYX) announced the addition of two prominent experts: Mark McKenna as ...